Gadolinium-enhanced cardiovascular magnetic resonance: administered dose in relationship to united states food and drug administration (FDA) guidelines

PURPOSE: Myocardial late gadolinium enhancement was originally validated using higher than label-recommended doses of gadolinium chelate. The objective of this study was to evaluate available evidence for various gadolinium dosing regimens used for CMR. The relationship of gadolinium dose warnings (...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Nacif, Marcelo S, Arai, Andrew E, Lima, Joao AC, Bluemke, David A
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2012
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3305456/
https://ncbi.nlm.nih.gov/pubmed/22376193
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1532-429X-14-18
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados